Starting on:
Jul 31, 2025
Ending on:
Jul 31, 2025
Moderator(s):
Go to activity
Max Credits:
2 Points
Provider:
International Cancer Institute
Claim Points
Jul 31, 2025
Ending on:
Jul 31, 2025
Moderator(s):
Prof.
Fredrick Asirwa
Prof. Fredrick Chite Asirwa M.D. is the CEO of International Cancer Institute, a not for-profit organization whose main purpose is to expand Education, Clinical Care and Training opportunities in cancer control and research across sub-Saharan Africa (SSA) through multi-sectoral collaborations and partnerships with relevant organizations both governmental and NGOs. Dr. Asirwa is a Medical Oncologist & Hematologist, PD/PI of several access to personalized cancer care and research initiatives including Blueprint Program (Kenya, Rwanda, Tanzania, Burundi, and Uganda), Shining Tower Program, Clinical Trials Program-all geared towards enhancing early detection, promoting primary HPV screening, providing SOC diagnostics & therapeutics cancer research. He has developed several training programs including SSA Oncology Preceptorship training, Digital Pathology Program, Telemedicine Program, Oncology training for Physician assistants (Clinical Officers), development of Oncology Nursing training program in Kenya, Medical Oncology Fellowship Program, Oncology Pharmacy program and assisted in the development of gynecologic oncology program. He has assisted in establishing 17 screening and early detection centers for breast and cervical cancers in Kenya working closely with the counties MOH and other local partners named EMPOWER clinics. Dr. Asirwa is also the PI of over 15 global multi-center Oncology and Hematology Clinical Trials in SSA. He was previously (2011-2019), the Director of Academic Model Providing Access to Health Care (AMPATH Oncology & Hematology Consortium) in Kenya- a consortium of a dozen Universities in the United States in partnership with Moi University and Moi Hospital in Eldoret, Kenya. In this role he conceptualized and developed infrastructure for telemedicine at AMPATH, created a robust hematology & oncology outreach program in rural Kenya and participated in the development of the Kenya National Cancer Control policies, strategic plans and guidelines by the National MOH. As PI to various clinical and research programs he established Multiple Myeloma program, Lymphoma Program, functional tumor registry, Integrated Breast & Cervical Cancer screening & treatment program, Hemophilia and Sickle cell diagnostics, treatment & research, EMR for Oncology care and screening, a multinational Lung Cancer Control Program, MLCCP (Kenya, South Africa, Lesotho, Tanzania, and Eswatini). He also teaches at various Universities in SSA and participates in Scientific Review Committees (SRC) and Data and Safety Monitoring Board (DSMB) of various Oncology/Hematology Clinical Trials both in the U.S. and SSA. He has also been an active ASCO member through ASCO’s Multidisciplinary Cancer Management Course (MCMC), International Affairs Committee (IAC), Education Council, ASCO‘s Academic Global Oncology Task Force, and as a Peer reviewer to ASCO Journals. He is also currently a member of ASCO-ESMO Global Oncology Curriculum committee, the International Association for the Study of Lung Cancer (IASLC) patient advocate committee, and one of the ASCO’s board of directors (2022-2026). He has been recognized for his work to increase access to cancer control for the underserved through various awards including the United States' National Cancer Institute's Pearline Global Cancer Research Humanitarian Award, 2020; The Children’s Place International 's 2018 Hero Award for his pioneering work in treating children and adults with cancers in Kenya. He was also awarded the 2023 Distinguished Leadership in Global Health Award by the Consortium Universities for Global Health (CUHG). He is the founder and current President of the College of Oncology of East, Central and Southern Africa (ECSA-CO) and a senate member for ECSA Health Community. He is also a distinguished Faculty speaker in both local, regional and International professional conferences and events including ASCO, ESMO, AORTIC, KESHO, Africa Cancer ECHO, APCA, UNGA, International Medical Educators Leadership Forum (IMELF), Aga Khan University’s Clinical Investigators Training Program (CITP) amongst others. He did his Undergraduate training (Bachelor of Medicine and Bachelor of Surgery) in Kenya and Post-graduate/specialty & sub-specialty training (Internal Medicine Residency & Heme/Onc Fellowship) in the United States
URL: Prof. Fredrick Chite Asirwa M.D. is the CEO of International Cancer Institute, a not for-profit organization whose main purpose is to expand Education, Clinical Care and Training opportunities in cancer control and research across sub-Saharan Africa (SSA) through multi-sectoral collaborations and partnerships with relevant organizations both governmental and NGOs. Dr. Asirwa is a Medical Oncologist & Hematologist, PD/PI of several access to personalized cancer care and research initiatives including Blueprint Program (Kenya, Rwanda, Tanzania, Burundi, and Uganda), Shining Tower Program, Clinical Trials Program-all geared towards enhancing early detection, promoting primary HPV screening, providing SOC diagnostics & therapeutics cancer research. He has developed several training programs including SSA Oncology Preceptorship training, Digital Pathology Program, Telemedicine Program, Oncology training for Physician assistants (Clinical Officers), development of Oncology Nursing training program in Kenya, Medical Oncology Fellowship Program, Oncology Pharmacy program and assisted in the development of gynecologic oncology program. He has assisted in establishing 17 screening and early detection centers for breast and cervical cancers in Kenya working closely with the counties MOH and other local partners named EMPOWER clinics. Dr. Asirwa is also the PI of over 15 global multi-center Oncology and Hematology Clinical Trials in SSA. He was previously (2011-2019), the Director of Academic Model Providing Access to Health Care (AMPATH Oncology & Hematology Consortium) in Kenya- a consortium of a dozen Universities in the United States in partnership with Moi University and Moi Hospital in Eldoret, Kenya. In this role he conceptualized and developed infrastructure for telemedicine at AMPATH, created a robust hematology & oncology outreach program in rural Kenya and participated in the development of the Kenya National Cancer Control policies, strategic plans and guidelines by the National MOH. As PI to various clinical and research programs he established Multiple Myeloma program, Lymphoma Program, functional tumor registry, Integrated Breast & Cervical Cancer screening & treatment program, Hemophilia and Sickle cell diagnostics, treatment & research, EMR for Oncology care and screening, a multinational Lung Cancer Control Program, MLCCP (Kenya, South Africa, Lesotho, Tanzania, and Eswatini). He also teaches at various Universities in SSA and participates in Scientific Review Committees (SRC) and Data and Safety Monitoring Board (DSMB) of various Oncology/Hematology Clinical Trials both in the U.S. and SSA. He has also been an active ASCO member through ASCO’s Multidisciplinary Cancer Management Course (MCMC), International Affairs Committee (IAC), Education Council, ASCO‘s Academic Global Oncology Task Force, and as a Peer reviewer to ASCO Journals. He is also currently a member of ASCO-ESMO Global Oncology Curriculum committee, the International Association for the Study of Lung Cancer (IASLC) patient advocate committee, and one of the ASCO’s board of directors (2022-2026). He has been recognized for his work to increase access to cancer control for the underserved through various awards including the United States' National Cancer Institute's Pearline Global Cancer Research Humanitarian Award, 2020; The Children’s Place International 's 2018 Hero Award for his pioneering work in treating children and adults with cancers in Kenya. He was also awarded the 2023 Distinguished Leadership in Global Health Award by the Consortium Universities for Global Health (CUHG). He is the founder and current President of the College of Oncology of East, Central and Southern Africa (ECSA-CO) and a senate member for ECSA Health Community. He is also a distinguished Faculty speaker in both local, regional and International professional conferences and events including ASCO, ESMO, AORTIC, KESHO, Africa Cancer ECHO, APCA, UNGA, International Medical Educators Leadership Forum (IMELF), Aga Khan University’s Clinical Investigators Training Program (CITP) amongst others. He did his Undergraduate training (Bachelor of Medicine and Bachelor of Surgery) in Kenya and Post-graduate/specialty & sub-specialty training (Internal Medicine Residency & Heme/Onc Fellowship) in the United States
Go to activity
Max Credits:
2 Points
Provider:
International Cancer Institute
Claim Points
INTERNATIONAL CANCER INSTITUTE VIRTUAL MULTIDISCIPLINARY TUMOR BOARD
Starting on:
Jul 31, 2025
Jul 31, 2025
Ending on:
Jul 31, 2025
Jul 31, 2025
Venue:
Description
International Cancer Institute invites you to attend the Virtual Multidisciplinary Tumor Board case presentation on solid cancers and hematological malignancies, followed by an expert discussion on patient Management. The multidisciplinary team will review recent advancements in oncology, cancer patients’ safety and health outcomes, interdisciplinary collaboration, and treatment plans. There will be a Q&A session with an open floor for insights
Objectives
To understand the management of various solid cancers and hematological malignancies
To understand the importance of integrating palliative and survivorship care in cancer management
To understand the importance of a multidisciplinary team approach in cancer management
Presenters
-
Dr.
Marcus Asuquo
I trained at the University of Calabar, earning a medical degree (MBBCh) in 1988. I worked as a junior research fellow at the Nigerian Institute of Medical Research (NIMR) for 5.6 years before beginning residency training. I completed my junior training at the University College Hospital (UCH) in Ibadan and advanced to senior training at the Lagos University Teaching Hospital (LUTH). In 2008, I was awarded the Fellowship of the National Postgraduate Medical College in Pathology (FMCPath (Haem)). In January 2010, I was appointed as a Lecturer I at the University of Calabar and as an Honorary Consultant Haematologist at the University of Calabar Teaching Hospital. Since then, I have been involved in teaching medical students, training residents in haematology, and conducting research. I have authored and contributed to several scholarly articles and books, secured research grants, and was the Principal Investigator for two studies: the 54 Gene Heritage study in Cross River State and the Unity Global Study for health workers exposed to COVID-19 in Nigeria. Was promoted to the post of Chief Consultant in the University of Calabar Teaching Hospital and to the rank of Associate Professor at the University of Calabar. Currently, I serve as the clinical consultant to Syndicate Bio, where I am involved in genome studies in Nigeria. My research interests include haemato-oncology, blood transfusion avoidance strategies, and Sickle Cell Anaemia. I lead the haemato-oncology unit of the department and have served as the National Secretary of the Nigerian Society for Haematology and Blood Transfusion (NSHBT) from 2014 to 2018. Additionally, I have been the National Secretary of the Cancer Education Advocacy Foundation of Nigeria (CEAFON) since 2013. I am a member of numerous professional associations. I serve as the chairman of the Neglected Cancers Committee of the Nigerian Cancer Society
International Cancer Institute -
Dr.
Powell Kanina
My name is Powell Kanina. I’m a General, Laparoscopic and Endoscopic surgeon. I work in Tigoni Level 4 hospital and in a number of private hospitals. I’m keen on PBM-Patient Blood Management.
International Cancer Institute